跳至主要内容
临床试验/JPRN-UMIN000038536
JPRN-UMIN000038536已完成3 期

Intradiscal injection therapy of platelet-rich plasma (PRP) - releasate for the patients with discogenic low back pain: Randomized control study - IDTPRCS

Mie University Hospital0 个研究点目标入组 17 人开始时间: 2020年12月1日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
17

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Having remarkable cauda equine and neuropathy symptom Having systematic or spinal infection Past-history of lumbar surgeries Past-history of interventional intervertebral disc therapy Having intervertebral instability evaluated by lumbar radiograph Patients having spondylolisthesis (more than grade I by Meyerding classification) Having neuro-muscular diseases, cerebral diseases, malignant tumor and blood coagulation disorders High risk for infectious diseases after the treatment Having anti-coagulant drugs at the time of treatment Pregnant patient Difficulty in participating throughout the evaluation period More than 10-points of BS-POS questionnaire test Contraindication for MRI Inappropriate patient for clinical study evaluate by doctors

研究者

相似试验

Intervertebral disc therapy using PRP-releasate | 临床试验